Concomitant administration of interleukin-2 during therapeutic vaccinations against cancer: the good, the bad, or the evil?
Andersen
Mads Hald
MH
Gehl
Julie
J
Reker
Sine
S
Geertsen
Poul
P
Becker
Jürgen C
JC
thor Stratem
Per
P
D018414:CD8-Positive T-Lymphocytes; D019496:Cancer Vaccines / Q000008:administration & dosage / Q000276:immunology* / Q000494:pharmacology*; D004334:Drug Administration Schedule; D006801:Humans; D007376:Interleukin-2 / Q000008:administration & dosage / Q000627:therapeutic use*; D008545:Melanoma / Q000188:drug therapy* / Q000276:immunology*; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000276:immunology*
D019496:Cancer Vaccines; D007376:Interleukin-2